Skip navigation
Home
About Us
Finance
Life Sciences
Life Sciences
Technology
Contact
All
TVM Capital News
Life Sciences News
Technology News
TVM Capital
About Us
TVM Capital is a global venture and growth capital firm with a 25 year operating track record. From our headquarters in Munich, and our office in Boston, we have financed more than 250 emerging …
→
Learn more…
Life Sciences
The TVM Capital Life Sciences Practice is a dedicated provider of venture and growth capital to the international biopharmaceutical industry. In more than 20 years of activity in the sector TVM Capital …
→
Learn more…
Technology
TVM Capital’s Technology Team is comprised of experienced and versatile executives who have the appropriate technological and business expertise to understand the complex needs of founders and …
→
Learn more …
Recent News
Life Sciences Events
Technology Events
Spotlight
02/01/2010
DIREVO Industrial Biotechnology Raises € 6 Million
01/28/2010
Ark - First Refractory Angina Patient treated with VEGF-D shortform (EG011) in...
01/28/2010
Cambridge Broadband partner with Gateway Communications to create world’s...
01/27/2010
EpiCept Receives Orphan Drug Designation for EpiCept(TM) NP-1 in U.S.
01/27/2010
Axxom achieves significant sales and profit growth The Munich-based technology...
01/26/2010
EpiCept Announces Ceplene(R) Included in Swedish AML Medical Guidelines
Geneva, Switzerland — March 10-11, 2010
EVCA Investors' Forum 2010
Barcelona, Spain — February 15-17, 2010
mobile world congress
TVM Capital Technology — December 2008
Portfolio Spotlight on CoreOptics
Nature Reviews Drug Discovery 7 — October 2008
Hepatitis C therapies
TVM Capital Life Sciences — July 2008
Specialized Growth Capital
TVM Capital Technology — March 2008
Portfolio Spotlight on Ubidyne
TVM Capital Life Science — February 2008
Spotlight on India
TVM Capital Life Sciences — January 2008
The Business of Innovation
→
Read more…
